Bioconjugate Chemistry · 2015 · 55 citations · 60 references
MedicineBiochemistryOncologyMolecular ImagingMolecular OncologyStructural BiologyLigand BindingMolecular Probe DevelopmentPeptide ChemistryProtein TargetingTargeted Imaging AgentsTumor Receptor ImagingIn Vivo ImagingMolecular Fluorescence ImagingMolecular Imaging Of CancerNear-infrared Fluorescence ImagingNear-infrared ProbesPeptide SpecificityPeptide-based Imaging AgentsProbe Optimization
We report the development, characterization, and validation of a peptide specific for the extracellular domain of HER2. This probe chemistry was developed for molecular imaging by using a structural model to select an optimal combination of amino acids that maximize the likelihood for unique hydrophobic and hydrophilic interactions with HER2 domain 3. The sequence KSPNPRF was identified and conjugated with either FITC or Cy5.5 via a GGGSK linker using Fmoc-mediated solid-phase synthesis to demonstrate flexibility for this chemical structure to be labeled with different fluorophores. A scrambled sequence was developed for control by altering the conformationally rigid spacer and moving both hydrophobic and hydrophilic amino acids on the C-terminus. We validated peptide specificity for HER2 in knockdown and competition experiments using human colorectal cancer cells in vitro, and measured a binding affinity of kd = 21 nM and time constant of k = 0.14 min(-1) (7.14 min). We used this peptide with either topical or intravenous administration in a preclinical model of colorectal cancer to demonstrate specific uptake in spontaneous adenomas and to show feasibility for real time in vivo imaging with near-infrared fluorescence. We used this peptide in immunofluorescence studies of human proximal colon specimens to evaluate specificity for sessile serrated and sporadic adenomas. Improved visualization can be used endoscopically to guide tissue biopsy and detect premalignant lesions that would otherwise be missed. Our peptide design for specificity to HER2 is promising for clinical translation in molecular imaging methods for early cancer detection.
60
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
Reiko Nishihara, Kana Wu, Paul Lochhead et al. · New England Journal of Medicine · 2013 · 1.5K citations · Full text
Quality Indicators for Colonoscopy
Douglas K. Rex, Philip Schoenfeld, Jonathan Cohen et al. · The American Journal of Gastroenterology · 2014 · 1.4K citations
Association of Colonoscopy and Death From Colorectal Cancer
Nancy N. Baxter · Annals of Internal Medicine · 2009 · 1.3K citations
Medicine, Biostatistics, Oncology +12
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
Matthew C. Franklin, Kendall D. Carey, F.F. Vajdos et al. · Cancer Cell · 2004 · 1.1K citations · Full text